Search results for "Osteoporosis"
Remote bone health service increased osteoporosis screening in high-risk men
A centralized screening program in Veterans Affairs primary care practices used an electronic tool to identify patients at risk for osteoporosis and a nurse case manager to coordinate screening and encourage initiation of treatment and adherence to therapy.
		
https://immattersacp.org/weekly/archives/2025/09/02/2.htm
		
 2 Sep 2025
		
Denosumab associated with hypocalcemia requiring treatment in patients with advanced CKD
The risk of hypocalcemia requiring ED or hospital care in patients taking denosumab appeared to increase with worsening chronic kidney disease (CKD) stage, with dialysis dependence, and with CKD-mineral and bone disorder, an analysis found.
		
https://immattersacp.org/weekly/archives/2024/11/19/1.htm
		
19 Nov 2024
		
New ACP paper reviews performance measures for osteoporosis
Of the six osteoporosis performance measures relevant to internal medicine physicians, only one is valid at three levels of attribution, i.e., individual physician, group practice, and health plan, an ACP assessment found.
		
https://immattersacp.org/weekly/archives/2023/10/10/6.htm
		
10 Oct 2023
		
Closing the gap on osteoporosis
A new clinical guideline from ACP focuses on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
		
https://immattersacp.org/archives/2023/05/closing-the-gap-on-osteoporosis.htm
		
 1 May 2023
		
ACP issues new osteoporosis guidance
The new clinical guideline from the College updates its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
		
https://immattersacp.org/weekly/archives/2023/01/03/1.htm
		
 3 Jan 2023
		
Traumatic fractures associated with subsequent fracture risk in postmenopausal women
Data from the Women's Health Initiative suggest that either a high-trauma or low-trauma fracture warrants evaluation for osteoporosis and counseling about fracture risk.
		
https://immattersacp.org/weekly/archives/2021/06/15/4.htm
		
15 Jun 2021
		
Bisphosphonates associated with lower fracture risk, not associated with mortality
Lower mortality rates linked to bisphosphonates in previous observational studies might be due to direct biological effects of treatment, authors of a recent meta-analysis noted.
		
https://immattersacp.org/weekly/archives/2019/08/27/4.htm
		
27 Aug 2019
		
Osteoporosis screening, treatment uncommon after stroke
Among 16,581 patients, 5.1% underwent poststroke bone mineral density testing and 15.5% received fracture prevention treatment within one year.
		
https://immattersacp.org/weekly/archives/2019/04/30/4.htm
		
30 Apr 2019
		
Guideline recommends pharmacologic treatment of osteoporosis in postmenopausal women at high fracture risk
Bisphosphonates are recommended for initial treatment, although ibandronate is not recommended for reducing nonvertebral or hip fracture risk, the clinical practice guideline from the Endocrine Society stated.
		
https://immattersacp.org/weekly/archives/2019/04/02/4.htm
		
 2 Apr 2019
		
Osteoporosis treatment often not started after hip fracture in elderly patients, study finds
The study found a continuous decline in starting osteoporosis treatment after hip fracture from 2004 to 2015, as well as a clinically meaningful reduction in rate of subsequent nonvertebral fracture in patients who did begin treatment versus those who did not.
		
https://immattersacp.org/weekly/archives/2018/07/24/4.htm
		
24 Jul 2018
		
ACR guideline recommends customized approach for prevention of glucocorticoid-induced osteoporosis
Recommendations include treating only with calcium and vitamin D in adults at low fracture risk, and adding an additional osteoporosis medication (oral bisphosphonate preferred) in adults at moderate to high fracture risk.
		
https://immattersacp.org/weekly/archives/2017/06/20/2.htm
		
20 Jun 2017
		
ACP strongly recommends generic bisphosphonates, denosumab to prevent fractures in women with osteoporosis
The guideline focuses on the comparative benefits and risks of short- and long-term drug treatments for low bone density or osteoporosis, including prescriptions, calcium, vitamin D, and estrogen.
		
https://immattersacp.org/weekly/archives/2017/05/09/1.htm
		
 9 May 2017
		
Benefits, harms of osteoporosis medications unclear for patients with CKD
Among several gaps in medical knowledge, there was conflicting or insufficient evidence of the effectiveness of bisphosphonates on fractures and safety in transplant recipients and patients with chronic kidney disease.
		
https://immattersacp.org/weekly/archives/2017/04/11/4.htm
		
11 Apr 2017
		
Act early to counter rise in osteoporosis
Recent studies indicate that late-life bone resiliency has been eroding, and newly released guidelines suggest diagnostic and treatment strategies to counteract that slide among women.
		
https://immattersacp.org/archives/2017/01/osteoporosis-care.htm
		
 1 Jan 2017
		
Repeat bone mineral density tests during osteoporosis treatment may help identify women at increased fracture risk, study finds
Monitoring bone mineral density in routine clinical practice may identify women with a suboptimal response to osteoporosis treatment who would benefit from closer follow-up, researchers noted.
		
https://immattersacp.org/weekly/archives/2016/07/19/1.htm
		
19 Jul 2016